Collaborations
Innate, Novo Nordisk partner to research and develop drugs targeting natural killer cells
Published in Biotech Business Week, May 4th, 2006
As part of the agreement Novo Nordisk will invest EUR 10 million in new Innate Pharma equity.
In contrast to most typical company collaborations focusing on a single disease, technology, or therapy, the Innate Pharma/Novo Nordisk partnership is broadly strategic, involving wide-ranging R&D based on NK cell biology. Innate Pharma founders' recent discoveries in the field of NKs...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
More Articles from Biotech Business Week
- Healthcare Costs
Study examines costs of acute coronary syndrome despite standard medical interventions - Market Analysis
Advantages, disadvantages of alliances for pharma industry detailed in report - Market Analysis
Biotech turns in mixed performance in the first quarter of 2006 - Market Analysis
Market research report examines U.S., European patent law and biopharmaceutical industry - Quality Assurance
Poll shows half of adults say quality assessable but few willing to pay more for better care - Acne
Survey suggests adults with acne scarring at a disadvantage at work and play - More from this issue of Biotech Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
